RBC Capital keeps a Buy rating and $82 price target on Cytokinetics (CYTK), saying the firm remains bullish on the stock following the ...

In a report released today, Manjari Dhar from RBC Capital maintained a Buy rating on Zalando (0QXN – Research Report), with a price target of ...

We recently published a list of 13 Best Defense Stocks to Buy According to Billionaires. In this article, we are going to ...

At RBC Capital Markets, Lori Calvasina lowered her bear case for the S&P 500 to 5,600 from 5,775 by year-end based on new ...

Investing.com -- Galderma Group AG has been downgraded by RBC Capital Markets to "sector perform" from "outperform," ...

Investing.com -- Several Wall Street firms have begun research coverage on Sailpoint Inc (NASDAQ: SAIL ), a U.S. company ...

Wall Street is on edge again, but the culprit this time isn’t just inflation. Instead, equities investors large and small are gripped by fear of slowing economic growth in the US. The S&P 500 Index ...

National Financial analyst Maxim Sytchev thinks negative macroeconomic sentiment has led to a “punitive” valuation for Aecon ...

S&P Dow Jones uses “float” – the value of shares that aren’t held by insiders and that therefore trade frequently and are ...

Barclays Plc hired John Kolz from Royal Bank of Canada to co-run global equity capital markets as it looks to the business to ...

Proficio Capital Partners LLC acquired a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC – Free Report) in the fourth ...